Pharmacogenomic Testing
Clinical laboratories should be familiar with the fundamentals of PGx, ensure that PGx testing meets the applicable regulatory requirements for all aspects of the clinical laboratory testing process, and follow recommendations for standardization of nomenclature and reporting.
Authors
- Karamatullah Danyal
- Nicole Mot
- Ann M. Moyer (ORCID: https://orcid.org/0000-0003-2590-7218)
- Geoffrey D. Wool (ORCID: https://orcid.org/0000-0002-3335-2905)
- Kristi J. Smock (ORCID: https://orcid.org/0000-0003-0304-6461)
- Honey V. Reddi (ORCID: https://orcid.org/0000-0003-1280-9993)
- Marvin R. Natowicz (ORCID: https://orcid.org/0000-0002-3018-546X)
- Paweł Mróz (ORCID: https://orcid.org/0000-0003-3838-4743)
- Loralie J. Langman
- Yuan Ji (ORCID: https://orcid.org/0000-0002-4369-647X)
- Bing Zhang (ORCID: https://orcid.org/0000-0002-1750-1659)
- Betsy Bove
- Lindsey Brunk
Institutions
- University of Minnesota (US)
- Cleveland Clinic (US)
- Mayo Clinic (US)
- College of American Pathologists (US)
- Southwestern Illinois College (US)
- University of Vermont Medical Center (US)
- University of Illinois Chicago (US)
- University of Chicago (US)
- ARUP Laboratories (United States) (US)
- Delaware Diamond Knives (United States) (US)
- Mayo Clinic in Arizona (US)
- Vanderbilt University Medical Center (US)
- Stanford University (US)
Publication Details
- Journal
- Archives of Pathology & Laboratory Medicine
- Published
- 2025-11-22
- DOI
- https://doi.org/10.5858/arpa.2025-0179-cp
- Primary Topic
- Pharmacogenetics and Drug Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 0.00